Vaccination against H5 avian influenza virus induces long-term humoral immune responses in flamingoes (Phoenicopterus spp.)

被引:2
|
作者
Fernandez-Bellon, Hugo [1 ,2 ]
Vergara-Alert, Julia [3 ]
Almagro, Vanessa [1 ,2 ]
Rivas, Raquel [3 ]
Sanchez, Azucena [4 ]
Carmen Martinez, Maria [4 ]
Majo, Natalia [2 ,3 ]
Busquets, Nuria [3 ]
Ramis, Antonio [2 ,3 ]
机构
[1] Parc Zool Barcelona, Parc Ciutadella S-N, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain
[3] CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona 08193, Spain
[4] Lab Cent Vet, Serv Virol, Ctra Algete,Km 8, Madrid 28110, Spain
关键词
Avian influenza; Zoo birds; Flamingo; Vaccination; Long-term immunity; H5N1; ZOO-BIRDS; HONG-KONG;
D O I
10.1016/j.vaccine.2016.04.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Avian influenza (AI) can represent a threat to endangered wild birds, as demonstrated with the H5N1 highly pathogenic AI (HPAI) outbreaks. Vaccination against AI using inactivated H5-vaccines has been shown to induce humoral immune response in zoo bird species. In this study, the long-term efficacy of H5-vaccination was evaluated in flamingoes from Barcelona Zoo. Specific H5-antibody titres were maintained at high levels (geometric mean titres >= 32) for over 7 years after vaccination, both against the H5N9 and H5N3 vaccine strains, as well as H5N3 and H5N1 reference strains. In addition the breadth of the immune response was also studied by testing antibody production against H1-, H3-, H4-, H7-, and H10 subtypes. It was observed that most flamingoes presented specific antibodies against H1 virus subtypes, but titres to the other HA-subtypes were rarely detected. We show that AI-vaccines can induce immunity lasting seven years in flamingoes, which suggests that vaccination can provide long term protection from HPAI outbreaks in zoo birds. (C) 2016 Published by Elsevier Ltd.
引用
收藏
页码:3082 / 3086
页数:5
相关论文
共 50 条
  • [21] Immunization with Plant-Derived Multimeric H5 Hemagglutinins Protect Chicken against Highly Pathogenic Avian Influenza Virus H5N1
    Phan, Hoang Trong
    Pham, Van Thi
    Ho, Thuong Thi
    Pham, Ngoc Bich
    Chu, Ha Hoang
    Vu, Trang Huyen
    Abdelwhab, Elsayed M.
    Scheibner, David
    Mettenleiter, Thomas C.
    Hanh, Tran Xuan
    Meister, Armin
    Gresch, Ulrike
    Conrad, Udo
    VACCINES, 2020, 8 (04) : 1 - 18
  • [22] Differences in Pathogenicity, Response to Vaccination, and Innate Immune Responses in Different Types of Ducks Infected with a Virulent H5N1 Highly Pathogenic Avian Influenza Virus from Vietnam
    Cagle, Caran
    Wasilenko, Jamie
    Adams, Sean C.
    Cardona, Carol J.
    Thanh Long To
    Tung Nguyen
    Spackman, Erica
    Suarez, David L.
    Smith, Diane
    Shepherd, Eric
    Roth, Jason
    Pantin-Jackwood, Mary J.
    AVIAN DISEASES, 2012, 56 (03) : 479 - 487
  • [23] Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria
    Dos Santos, Carina Carvalho
    Rodriguez, Dunia
    Issamu, Alex Kanno
    De Cerqueira Leite, Luciana Cezar
    Nascimento, Ivan Pereira
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (03) : 673 - 683
  • [24] Protective Dose of a Recombinant Newcastle Disease LaSota-Avian Influenza Virus H5 Vaccine Against H5N2 Highly Pathogenic Avian Influenza Virus and Velogenic Viscerotropic Newcastle Disease Virus in Broilers with High Maternal Antibody Levels
    Sarfati-Mizrahi, David
    Lozano-Dubernard, Bernardo
    Soto-Priante, Ernesto
    Castro-Peralra, Felipa
    Flores-Castro, Ricardo
    Loza-Rubio, Elizabeth
    Gay-Gutierrez, Manuel
    AVIAN DISEASES, 2010, 54 (01) : 239 - 241
  • [26] Improved immune responses against avian influenza virus following oral vaccination of chickens with HA DNA vaccine using attenuated Salmonella typhimurium as carrier
    Jazayeri, Seyed Davoud
    Ideris, Aini
    Zakaria, Zunita
    Yeap, Swee Keong
    Omar, Abdul Rahman
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2012, 35 (05) : 417 - 427
  • [27] Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus
    Kapczynski, Darrell R.
    Esaki, Motoyuki
    Dorsey, Kristi M.
    Jiang, Haijun
    Jackwood, Mark
    Moraes, Mauro
    Gardin, Yannick
    VACCINE, 2015, 33 (09) : 1197 - 1205
  • [28] Rapid Construction and Immunogenicity Testing of a Novel H5 Virus-Like Particle Prototype Vaccine Against Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Virus
    Penzes, Zoltan
    Czegledi, Aliz
    Nagy, Zoltan
    Kollar, Anna
    Toth, Adam
    Misak, Ferenc
    Rendes, Katalin
    Ivok, Marianna
    Gyimesi, Reim
    Lovrecz, George
    Tretyakoya, Irina
    El-Attrache, John
    Palya, Vilmos
    Pushko, Peter
    AVIAN DISEASES, 2019, 63 (01) : 203 - 208
  • [29] Mucosal Administration of Lactobacillus casei Surface-Displayed HA1 Induces Protective Immune Responses against Avian Influenza A Virus in Mice
    Huynh, Dung T.
    Chathuranga, W. A. Gayan
    Chathuranga, Kiramage
    Lee, Jong -Soo
    Kim, Chul-Joong
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2024, 34 (03) : 735 - 745
  • [30] Single Vaccination Provides Limited Protection to Ducks and Geese Against H5N1 High Pathogenicity Avian Influenza Virus
    Eggert, Dawn
    Swayne, David E.
    AVIAN DISEASES, 2010, 54 (04) : 1224 - 1229